Isagenix International recently announced that it has added Joshua Plant, Ph.D., to its executive leadership team as its chief science officer.
In his new role, Plant will oversee the research and development, product design and development, product commercialization, and quality assurance of all Isagenix products.
Plant has also been named chairman of the Isagenix Scientific Advisory Board, a group of top medical and health professionals who lend their experience and expertise to ensure the integrity and effectiveness of Isagenix products. Board members include Isagenix Founder John W. Anderson.
“Joshua is incredibly bright and has great expertise in preventative health and nutritional sciences, which has earned him respect in both the health and wellness and direct selling industries,” said Isagenix Chief Executive Officer Travis Ogden. “His experience will be instrumental in creating exceptional, innovative products that resonate with customers and help Isagenix transform lives around the world.”
Plant’s experience prior to joining Isagenix includes a position as a research fellow at the University of Utah, where he earned a Bachelor of Science in biology, making him a first-generation college student. In addition, he received the prestigious National Institutes of Health International Research Fellowship, given to only 10 students each year. Plant also has a doctorate in biomedical sciences from Harvard University, where he graduated first in his class and completed a seven-year program in three and a half years.
“Isagenix has a terrific reputation and has done stellar work in the health and wellness space,” he said. “I’m thrilled to be part of a company that has made it possible for hundreds of thousands of people to embrace and enjoy a healthy lifestyle, and I look forward to playing a part in its continued success and growth.”
